Publications by authors named "Karyn A Bolton"

2 Publications

  • Page 1 of 1

Effect of oxysterols on hematopoietic progenitor cells.

Exp Hematol 2002 Jul;30(7):670-8

Stem Cell Laboratory, The Douglas Hocking Research Institute, The Geelong Hospital, Victoria, Australia.

Objectives: Oxysterols are hydroxylated derivatives of cholesterol detected in blood, cells, and tissues. They exhibit a number of biologic activities, including inhibition of cellular proliferation and cytotoxicity associated with induction of apoptosis. Given the important regulatory role of apoptosis in hematopoiesis, we investigated the effects of oxysterols on human hematopoietic progenitor cells (HPCs).

Materials And Methods: Colony-forming unit granulocyte-macrophage (CFU-GM) from human bone marrow and umbilical cord blood (UCB) were grown in the presence of varying concentrations of three different oxysterols-7-keto-cholesterol, 7-beta-hydroxycholesterol, and 25-hydroxycholesterol (25-OHC). Similarly, the effect of oxysterols on HL60 and CD34+ cells was investigated using annexin V staining and flow cytometry to measure apoptosis. Reduction of nitroblue tetrazolium was used to assess differentiative status of HL60 cells.

Results: CFU-GM derived from human bone marrow were inhibited by all three oxysterols tested, with 25-OHC being the most potent. In comparison, CFU-GM derived from UCB were less sensitive to the effects of all the oxysterols tested, with statistically significant inhibition observed only in the presence of 25-OHC. Oxysterol treatment of HL60 cells inhibited cell growth and increased the number of annexin V+ and nitroblue tetrazolium+ cells. The percentage of viable, CD34+ annexin V+ cells also was increased with oxysterol treatment of purified HPCs in liquid culture.

Conclusions: These experiments indicate that oxysterol inhibition of CFU-GM and HL60 cell growth can be attributed to induction of apoptosis and/or differentiation. These investigations revealed that oxysterols are a new class of inhibitors of HPC proliferation of potential relevance in vivo and in vitro.
View Article and Find Full Text PDF

Download full-text PDF

Source Listing
July 2002

MERP1: a mammalian ependymin-related protein gene differentially expressed in hematopoietic cells.

Gene 2002 Mar;286(2):249-57

Stem Cell Laboratory, The Douglas Hocking Research Institute, Barwon Health, The Geelong Hospital, Geelong, VIC, 3220, Australia.

We have utilized differential display polymerase chain reaction to investigate the gene expression of hematopoietic progenitor cells from adult bone marrow and umbilical cord blood. A differentially expressed gene was identified in CD34+ hematopoietic progenitor cells, with low expression in CD34- cells. We have obtained the full coding sequence of this gene which we designated human mammalian ependymin-related protein 1 (MERP1). Expression of MERP1 was found in a variety of normal human tissues, and is 4- and 10-fold higher in adult bone marrow and umbilical cord blood CD34+ cells, respectively, compared to CD34- cells. Additionally, MERP1 expression in a hematopoietic stem cell enriched population was down-regulated with proliferation and differentiation. Conceptual translation of the MERP1 open reading frame reveals significant homology to two families of glycoprotein calcium-dependant cell adhesion molecules: ependymins and protocadherins.
View Article and Find Full Text PDF

Download full-text PDF

Source Listing
March 2002